Reperfusion

Penumbra announced it received FDA 510(k) clearance for its reperfusion catheter system designed to help clinicians navigate complex distal vessel anatomy in large vessel occlusion acute ischemic stroke.

Among patients with cancer who experienced a stroke, reperfusion therapy conferred similar short-term outcomes as in patients with stroke and nonactive cancer or no history of cancer, researchers reported.

An adjustable clot retriever device for large vessel occlusion ischemic stroke was demonstrated to be both more effective and safer compared with prior data on other stent-retriever devices, a speaker reported.

Safety and efficacy of prehospital administration of crushed prasugrel (Effient, Daiichi Sankyo/Eli Lilly) vs. uncrushed tablets in patients with STEMI.

In the COMPARE CRUSH trial, administration of crushed prasugrel tablets in patients with STEMI on the way to the hospital planned for primary PCI did not improve coronary reperfusion.

Among patients who required interhospital transfer for STEMI, nearly 40% had cath lab activation times of less than 20 minutes, which were linked to prompt PCI, researchers reported.